MEERA SUTHAR: Open Payments
NPI 1184950388 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 20 payments from 11 companies in 2025. Trend: 2023 $1,210 · 2024 $817 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| CORDIS US CORP. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Amgen Inc. | 5 | $90 |
| Novo Nordisk Inc | 2 | $52 |
| Calliditas Therapeutics US Inc. | 2 | $47 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| CVRx, Inc. | 1 | $17 |
Products named: S.M.A.R.T. CONTROL, JYNARQUE, TAVNEOS, Ozempic, TARPEYO, PURIFIED CORTROPHIN GEL, INJECTAFER, FARXIGA.
Industry payments across SC — which companies pay providers there.
